Pro Medicus Limited (ASX: PME)
Pro Medicus Limited is a leading health imaging company known for its innovative healthcare technology solutions. The company's subsidiary, Visage Imaging, Inc., offers a cutting-edge cloud-based Visage 7 Enterprise Imaging Platform, which is designed to revolutionize diagnostic imaging in healthcare settings. PME has recently made significant strides in the North American healthcare IT market by securing substantial contracts with integrated delivery networks (IDNs) and academic medical centers, positioning itself as a key player in the industry.
Pro Medicus Limited Signs AUD $140 million Deal with Baylor Scott & White Health (BSWH)
Talon Energy Limited (ASX: TPD)
Talon Energy Limited is an energy company that operates in the resources sector. Notably, TPD is involved in the development and production of domestic gas resources. The company, in partnership with Strike Energy Limited (ASX: STX), has achieved a significant milestone with the commissioning of the Walyering gas field in Western Australia. This achievement marks TPD's transition from an explorer to a producer and plays a pivotal role in addressing the domestic gas supply in the region.
Strike Energy Limited (ASX: STX) and Talon Energy Limited (ASX: TPD) Announce Walyering Gas Field Update
These developments highlight the growth and strategic advancements of ASX-listed companies PME and TPD in the healthcare and energy sectors, respectively.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Mar 28, 2025
Mar 28, 2025
Mar 28, 2025
Mar 27, 2025
Mar 27, 2025
Mar 27, 2025
Mar 26, 2025
Mar 26, 2025
Mar 26, 2025
Mar 25, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.